14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate

Base Information

• Chemical Name: 14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate
• CAS No.: 76958-99-1
• Molecular Formula: C28H36 O10 . K
• Molecular Weight: 570.672
• Mol file: 76958-99-1.mol

Synonyms:Butanedioicacid,mono[[(1R,2R,4aR,5R,8aS)-2-(3-carboxy-1-oxopropoxy)-5-[(1E)-2-(2,5-dihydro-2-oxo-3-furanyl)ethenyl]decahydro-1,4a-dimethyl-6-methylene-1-naphthalenyl]methyl]ester, monopotassium salt (9CI); Butanedioic acid,mono[[2-(3-carboxy-1-oxopropoxy)-5-[2-(2,5-dihydro-2-oxo-3-furanyl)ethenyl]decahydro-1,4a-dimethyl-6-methylene-1-naphthalenyl]methyl]ester, monopotassium salt, [1R-[1a,2a,4aa,5a(E),8ab]]-;14-Deoxy-11,12-didehydroandrographolide 3,19-disuccinate monopotassium salt;Chuanhuning; Potassium dehydroandrographolide succinate

Chemical Property of 14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate

Chemical Property:

• Vapor Pressure: 1.48E-23mmHg at 25°C
• Boiling Point: 733.8°C at 760 mmHg
• Flash Point: 239.1°C
• PSA: 156.33000
• LogP: 2.26450

Purity/Quality:

95%, ^*data from raw suppliers

KaliiDehydrographolidiSuccinas ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Description: This product was included in national standards for chemical drugs. Injection, freeze-dried powder injection. Used for viral pneumonia and viral upper respiratory tract infection
• Physical properties: Appearance: white to yellowish crystalline powder, odorless, bitter, slightly wetting. Solubility: slightly soluble in ethanol, insoluble in chloroform, dissolved in 1% sodium bicarbonate solution.
• Indications: This product is contained in the Pharmacopoeia of the People’s Republic of China (2010). Injection, freeze-dried powder injection. Used for viral pneumonia and viral upper respiratory tract infection.
• Clinical Use: Potassium dehydroandrographolide succinate is widely used in the treatment of viral pneumonia, influenza virus-induced acute upper respiratory tract infection, acute bronchitis, pediatric bronchial pneumonia, dysentery, epidemic encephalitis, and asthma attacks, especially for viral and bacterial respiratory tract infections, and has a significant effect on dysentery, especially for infant pneumonia . Clinically, potassium sodium dehydroandrographolide succinate is mainly used for the treatment of upper respiratory tract infection, bronchial pneumonia, viral pneumonia, viral enteritis, and hand, foot, and mouth disease .